Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 23:37:08 GMT 2025
by
admin
on
Mon Mar 31 23:37:08 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY CONJUGATE |
| Protein Sub Type | IGG1 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
44OUQ00D1U
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C575
Created by
admin on Mon Mar 31 23:37:08 GMT 2025 , Edited by admin on Mon Mar 31 23:37:08 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Vandortuzumab vedotin
Created by
admin on Mon Mar 31 23:37:08 GMT 2025 , Edited by admin on Mon Mar 31 23:37:08 GMT 2025
|
PRIMARY | |||
|
10018
Created by
admin on Mon Mar 31 23:37:08 GMT 2025 , Edited by admin on Mon Mar 31 23:37:08 GMT 2025
|
PRIMARY | |||
|
44OUQ00D1U
Created by
admin on Mon Mar 31 23:37:08 GMT 2025 , Edited by admin on Mon Mar 31 23:37:08 GMT 2025
|
PRIMARY | |||
|
DE-26
Created by
admin on Mon Mar 31 23:37:08 GMT 2025 , Edited by admin on Mon Mar 31 23:37:08 GMT 2025
|
PRIMARY | |||
|
1471985-92-8
Created by
admin on Mon Mar 31 23:37:08 GMT 2025 , Edited by admin on Mon Mar 31 23:37:08 GMT 2025
|
PRIMARY | |||
|
C116748
Created by
admin on Mon Mar 31 23:37:08 GMT 2025 , Edited by admin on Mon Mar 31 23:37:08 GMT 2025
|
PRIMARY | |||
|
100000175817
Created by
admin on Mon Mar 31 23:37:08 GMT 2025 , Edited by admin on Mon Mar 31 23:37:08 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_151 | 1_207 |
| 1_268 | 1_328 |
| 1_374 | 1_432 |
| 2_22 | 2_96 |
| 2_151 | 2_207 |
| 2_268 | 2_328 |
| 2_374 | 2_432 |
| 3_23 | 3_94 |
| 3_140 | 3_200 |
| 4_23 | 4_94 |
| 4_140 | 4_200 |
| 1_227 | 3_220 |
| 2_227 | 4_220 |
| 1_233 | 2_233 |
| 1_236 | 2_236 |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_304 |
| N | 2_304 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
DERIVATIVE -> PARENT | |||
|
|
TARGET->CONJUGATED TOXIN | |||
|
|
PARENT -> CONJUGATE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | [1_227] [1_233] [1_236] [2_220] [2_233] [2_236] [3_220] [4_220] | C |
Amount:
|
Cysteinyl vedotin | 6603L01WUR |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|